IGNYTA
Ignyta is a scientifically-driven biotechnology company catalyzing personalized medicine in autoimmune diseases. Their goal is to revolutionize the quality of biomarkers and tests available to rheumatologists and patients to help them make better informed, more individualized treatment decisions; and to identify truly novel autoimmune disease targets for biopharmaceutical companies to enable the development of precise therapies for patients worldwide. Ignyta was incorporated in 2011 and operates in San Diego, California.
IGNYTA
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2011-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.ignyta.com
Total Employee:
101+
Status:
Closed
Contact:
(858)255-5959
Email Addresses:
[email protected]
Total Funding:
375.5 M USD
Technology used in webpage:
SPF Domain Not Resolving IPv6 ReCAPTCHA Microsoft Azure DNS YouTube IIS DigiCert SSL Microsoft GoDaddy
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2013-05-20 | Actagene Oncology | Actagene Oncology acquired by Ignyta | N/A |
Investors List
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Ignyta
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Ignyta
Teva Pharmaceutical Industries
Teva Pharmaceutical Industries investment in Post-IPO Equity - Ignyta
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Ignyta
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Ignyta
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Debt Financing - Ignyta
Casdin Capital
Casdin Capital investment in Venture Round - Ignyta
City Hill Ventures
City Hill Ventures investment in Series B - Ignyta
Colt Ventures
Colt Ventures investment in Series B - Ignyta
Silicon Valley Bank
Silicon Valley Bank investment in Series B - Ignyta
Newest Events participated
Official Site Inspections
http://www.ignyta.com
- Host name: 241.131.168.184.host.secureserver.net
- IP address: 184.168.131.241
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Ignyta"
Ignyto - Leading Platinum Salesforce Partner in the UK, Ireland
"Ignyto were integral to the re-development and implementation on our Salesforce platform. As …See details»
Meet Your Salesforce Team - The Salesforce Experts - Ignyto
E: [email protected] T: +353 1 968 2544 London (by appointment only) 27 Old Gloucester …See details»
Ignyto: Platinum Salesforce Partner Dublin, Manchester ... - LinkedIn
Summit / Platinum Level Salesforce Consultants, Integration & Implementation Specialists in …See details»
Ignyto - Overview, News & Similar companies | ZoomInfo.com
Mar 22, 2023 Who is Ignyto. Ignyto is a Gold level Salesforce Partner based in London, …See details»
IGNYTO LIMITED Company Profile - Dun & Bradstreet
IGNYTO LIMITED Company Profile | LONDON, United Kingdom | Competitors, Financials & …See details»
Ignyta Inc - Company Profile and News - Bloomberg Markets
Company profile page for Ignyta Inc including stock price, company news, executives, board …See details»
Ignyta Company Profile - Office Locations, Competitors ... - Craft
See insights on Ignyta including office locations, competitors, revenue, financials, executives, …See details»
Contact your Salesforce Team in Dublin, London, Manchester
E: [email protected] T: +353 1 968 2544 London (by appointment only) 27 Old Gloucester …See details»
Ignyto: Platinum Salesforce Partner Dublin, Manchester ... - LinkedIn
Ignyto: Platinum Salesforce Partner Dublin, Manchester, London and Stockholm | 1,578 …See details»
Ignyta - VentureRadar
Ignyta, Inc., located in San Diego, California, is a personalized medicine company developing …See details»
Ignyta, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Ignyta, Inc. …See details»
Teva and Ignyta Announce Acquisition by Ignyta ... - Teva …
Mar 17, 2015 Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) (“Teva”), a world leading …See details»
Ignyta Company Profile 2024: Valuation, Investors, Acquisition
Ignyta General Information Description. Ignyta is an oncology biotechnology company. Its …See details»
Diversity, Equality and Inclusion Excellence at Ignyto
E: [email protected] T: +353 1 968 2544 London (by appointment only) 27 Old Gloucester …See details»
Ignyta - Products, Competitors, Financials, Employees, …
Ignyta, formerly NexDx, specializes in precision medicine and biotechnology, with an integrated …See details»
Roche pays $1.7 billion for cancer specialist Ignyta
Nov 1, 2024 Roche is to bolster its cancer pipeline with the $1.7 billion acquisition of Ignyta. …See details»
Ignyto Salesforce Client Success - Case Studies - Ignyto
"Ignyto were integral to the re-development and implementation on our Salesforce platform. As …See details»
Ignyta, Inc. Careers and Employment | Indeed.com
Find out what works well at Ignyta, Inc. from the people who know best. Get the inside scoop …See details»
Enhance Your Company's Team Collaboration with Ignyto’s New …
How Ignyto’s Slack Services Drive Business Growth Our Slack Services go beyond basic …See details»
Salesforce Forecasting & Pipeline Management - News - Ignyto
Managing pipeline and forecasting is an essential operation of any organization as it provides …See details»